Dysregulation of MPC in type 2 diabetes may exacerbate insulin resistance by limiting pyruvate availability for mitochondrial oxidation and promoting the accumulation of metabolic intermediates, such as diacylglycerols and ceramides, which are known to interfere with insulin signaling pathways [33]. The gene discussed is INS; the disease is Insulin resistance.